Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: A systematic review

被引:68
作者
Gerestein, Cornelis G. [1 ,3 ]
Damhuis, Ronald A. M. [2 ]
Burger, Curt W. [3 ]
Kooi, Geertruida S. [1 ]
机构
[1] Albert Schweitzer Hosp, Dept Obstet & Gynecol, Dordrecht, Netherlands
[2] Rotterdam Canc Registry, Rotterdam, Netherlands
[3] Univ Med Ctr, Daniel Den Hoed Erasmus MC, Dept Obstet & Gynecol, Div Gynecol Oncol, Rotterdam, Netherlands
关键词
Postoperative mortality; 30-day mortality; Ovarian cancer; Primary cytoreductive surgery; Advanced stage; PRIMARY PERITONEAL CANCER; NEOADJUVANT CHEMOTHERAPY; SURGICAL CYTOREDUCTION; GYNECOLOGIC ONCOLOGISTS; PRIMARY DEBULKING; BOWEL RESECTION; FALLOPIAN-TUBE; ELDERLY-WOMEN; CARCINOMA; SURVIVAL;
D O I
10.1016/j.ygyno.2009.03.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Accurate estimation of the risk of postoperative mortality (POM) is essential for the decision whether or not to perform cytoreductive surgery in a patient with advanced stage ovarian cancer. To ascertain modern reference figures, a systematic review of studies reporting POM after primary cytoreductive surgery for advanced stage epithelial ovarian cancer (EOC) was performed. Materials and methods. A Medline search was performed to retrieve papers on primary cytoreductive surgery for advanced stage EOC. Twenty-three papers met the inclusion criteria and were reviewed. Results. According to population-based studies, POM after primary cytoreductive surgery for EOC is 3.7% on average. Single centre studies report an average rate of 2.5%. The overall mean POM is 2.8%. POM is more frequent for elderly women and after extensive procedures. Accurate information on age-specific and procedure-specific rates could not be obtained. Conclusion. POM rates after surgery for EOC are satisfactorily low. There is a clear need for reliable reference figures for mortality after debulking surgery in the elderly. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:523 / 527
页数:5
相关论文
共 56 条
[1]   Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Podratz, KC ;
Cliby, WA .
GYNECOLOGIC ONCOLOGY, 2006, 100 (02) :283-287
[2]   A new frontier for quality of care in gynecologic oncology surgery: Multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model [J].
Aletti, Giovanni D. ;
Santillan, Antonio ;
Eisenhauer, Eric L. ;
Hu, Jae ;
Aletti, Giacomo ;
Podratz, Karl C. ;
Bristow, Robert E. ;
Chi, Dennis S. ;
Cliby, William A. .
GYNECOLOGIC ONCOLOGY, 2007, 107 (01) :99-106
[3]   Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer [J].
Alphs, Hannah H. ;
Zahurak, Marianna L. ;
Bristow, Robert E. ;
Diaz-Montes, Teresa P. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (03) :1048-1053
[4]   The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark [J].
Andersen, ES ;
Knudsen, A ;
Svarrer, T ;
Lund, B ;
Nielsen, K ;
Grove, A ;
Tetsche, M .
GYNECOLOGIC ONCOLOGY, 2005, 99 (03) :552-556
[5]  
[Anonymous], 1987, Am J Obstet Gynecol, V156, P263
[6]   The influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancer [J].
Ayhan, A ;
Al, RA ;
Baykal, C ;
Demirtas, E ;
Ayhan, A ;
Yüce, K .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (01) :51-56
[7]   Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer [J].
Black, Destin ;
Iasonos, Alexia ;
Ahmed, Hina ;
Chi, Dennis S. ;
Barakat, Richard R. ;
Abu-Rustum, Nadeem R. .
GYNECOLOGIC ONCOLOGY, 2007, 107 (01) :66-70
[8]   Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer center [J].
Board, RE ;
Bruijns, CTPH ;
Pronk, AE ;
Ryder, WDJ ;
Wilkinson, PM ;
Welch, R ;
Shanks, JH ;
Connolly, G ;
Slade, RJ ;
Reynolds, K ;
Kitchener, HC ;
Jayson, GC .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 :18-24
[9]   Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer [J].
Bristow, RE ;
Montz, FJ ;
Lagasse, LD ;
Leuchter, RS ;
Karlan, BY .
GYNECOLOGIC ONCOLOGY, 1999, 72 (03) :278-287
[10]   Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator [J].
Bristow, RE ;
Montz, FJ .
GYNECOLOGIC ONCOLOGY, 2001, 83 (01) :39-48